2025-00357Notice

Advisory Committee; Antimicrobial Drugs Advisory Committee; Renewal

Published Date: 1/10/2025

Notice

Summary

The FDA is renewing its Antimicrobial Drugs Advisory Committee for two more years, keeping it active until October 7, 2026. This committee helps make sure medicines fighting infections are safe and work well, with experts from different health fields giving advice. No big changes in money or timing—just a smooth continuation to keep the good work going!

No Economic Impacts Identified for this Document

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Effective Date
Published Date
12/31/2024
1/10/2025

Department and Agencies

Department
Independent Agency
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register